Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Wiley
2020
|